08Dec/09

US panel backs Novartis transplant drug — FDA – Reuters

US panel backs Novartis transplant drug — FDA
Reuters
VX) drug to prevent rejection of transplanted kidneys, a Food and Drug Administration spokeswoman said on Monday. The panel voted 11-1 to urge FDA clearance
Panel Recommends Everolimus in Kidney TransplantMedPage Today
FDA Panel Recommends Agency OK Novartis Kidney DrugWall Street Journal
Advisory panel recommends everolimus tablets for approvalCardiology Today

all 12 news articles »